Filing Details

Accession Number:
0000950170-23-026845
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-07 17:04:21
Reporting Period:
2023-06-05
Accepted Time:
2023-06-07 17:04:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1785173 89Bio Inc. ETNB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1423327 Rohan Palekar C/O 89Bio, Inc.
142 Sansome Street, 2Nd Floor
San Francisco CA 94104
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-05 15,000 $1.93 301,978 No 4 M Direct
Common Stock Disposition 2023-06-05 15,000 $20.00 286,978 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-06-05 15,000 $0.00 15,000 $1.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
195,231 2028-11-09 No 4 M Direct
Footnotes
  1. Includes an aggregate of 8 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on December 30, 2022.
  2. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2022.
  3. This option is vested in full.
  4. Due to an administrative error, the exercise of an aggregate of 15,000 options was erroneously omitted from the Form 4 filed by the Reporting Person on March 27, 2023. This form reflects the correct amount of stock options owned by the Reporting Person.